Home
Inside Ensoma
Our Science
Pipeline
Careers
News
Contact
Ensoma
Inside Ensoma
About Us
Leadership
Board of Directors
Scientific Advisors
Investors
Our Science
Pipeline
Careers
News
Press Releases
Presentations
Publications
In the News
Contact
In vivo base editing by a single intravenous vector injection for treatment of hemoglobinopathies
Post navigation
Previous:
In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4
Next:
In vivo HSC prime editing rescues sickle cell disease in a mouse model